KCG
ARIA

Knight Capital Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Knight Capital Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$249K Buy
+14,237
New +$252K ﹤0.01% 2476

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Knight Capital Group's ARIA Position: Q2 2013 in Review

Knight Capital Group opened a new position in Ariad Pharmaceuticals Inc (ARIA) in Q2 2013: 14,237 shares worth $249K. The stake represents ﹤0.01% of the portfolio and ranks #2476 among its holdings.

198 funds tracked by Wall St. Rank hold ARIA as of Q2 2013.

  • Knight Capital Group held 14,237 shares of Ariad Pharmaceuticals Inc worth $249K as of Q2 2013.
  • Ariad Pharmaceuticals Inc was a new Knight Capital Group position in Q2 2013.
  • Ariad Pharmaceuticals Inc made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2476 holding.
  • 198 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.